Curable compositions comprising telechelic polyolefins
The present disclosure relates to novel telechelic polyolefins of the formula (I) and processes for preparing the same. The present disclosure further relates to curable formulations comprising the telechelic polyolefin of the formula (I).
1 . A curable formulation comprising (a) from 80 wt % to 99.99 wt % of a telechelic polyolefin, and (b) from 0.01 wt % to 20 wt % of a curing component comprising a crosslinking agent, wherein the telechelic polyolefin has the formula (I):
A 1 L 1 L 2 A 2 (I);
L 1 is an ethylene/alpha-olefin copolymer comprising units derived from greater than or equal to 50 wt % of ethylene and a C 3 to C 30 alpha-olefin;
A 1 is selected from the group consisting of a vinyl group, a vinylidene group of the formula CH 2 ═C(Y 1 )—, a vinylene group of the formula Y 1 CH═CH—, a mixture of a vinyl group and a vinylene group of the formula Y 1 CH═CH—, a mixture of a vinyl group and a vinylidene group of the formula CH 2 ═C(Y 1 )—, a mixture of a vinylidene group of the formula CH 2 ═C(Y 1 )— and a vinylene group of the formula Y 1 CH═CH—, and a mixture of a vinyl group, a vinylidene group of the formula CH 2 ═C(Y 1 )—, and a vinylene group of the formula Y 1 CH═CH—;
Y 1 at each occurrence independently is a C 1 to C 30 hydrocarbyl group;
L 2 is a C 1 to C 32 hydrocarbyl group; and
A 2 is a hydrocarbyl group selected from the group consisting of:
wherein the endocyclic double bond in (AC) and (AF) may be between any two adjacent carbon atoms that are ring members, and wherein the pendant methyl group of (AF) may be connected to any carbon atom that is a ring member.
2 . The formulation of any of claim 1 , wherein the C 3 to C 30 alpha-olefin is selected from the group consisting of propylene, 1-butene, 1-hexene, and 1-octene.
3 . The formulation of claim 1 , wherein the telechelic polyolefin of the formula (I) comprises a weight average molecular weight (Mw) range from 1,000 to 1,000,000 g/mol.
4 . The formulation of claim 1 , wherein L 1 is covalently bonded to each of A 1 and L 2 through carbon-carbon single bonds, and wherein L 2 is covalently bonded to A 2 through a carbon-carbon single bond.
5 . The formulation of claim 1 , wherein the (b) curing component further comprises a co-agent.
6 . The formulation of claim 1 , wherein the cross-linking agent is a peroxide.
7 . The formulation of claim 1 further comprising (c) an additive component.
8 . The formulation of claim 1 , wherein the (c) additive component comprises zinc oxide and/or stearic acid.